Jing Qu

Find an error

Name:
Organization: Institute of Materia Medica
Department: State Key Laboratory of Bioactive Substance and Function of Natural Medicines
Title:
Co-reporter:Fangyi Su, Zheng Zhao, Shuanggang Ma, Rubing Wang, Yong Li, Yunbao Liu, Yuhuan Li, Li Li, Jing Qu, and Shishan Yu
Organic Letters September 15, 2017 Volume 19(Issue 18) pp:
Publication Date(Web):August 31, 2017
DOI:10.1021/acs.orglett.7b02290
Three pairs of racemic dimers, (±)-cnidimonins A–C (1–3), were isolated from the fruits of Cnidium monnieri. They represent novel hybrid-dimerization patterns of coumarin skeleton with structurally diverse units (flavonol, benzofuran, and chromone) via an unprecedented terminal chiral carbon of prenyl. The absolute configurations of the enantiomers were determined by electronic circular dichroism (ECD). To investigate their bioactivities in depth, (±)-cnidimonins A–C (1–3) were synthesized. The racemic mixture (±)-1 exhibited stronger antiviral activity against HSV-1 (IC50: 1.23 μM) than its corresponding optically pure enantiomers.
Co-reporter:Shuang-Gang Ma, Mi Li, Ming-Bao Lin, Li Li, Yun-Bao Liu, Jing Qu, Yong Li, Xiao-Jing Wang, Ru-Bing Wang, Song Xu, Qi Hou, and Shi-Shan Yu
Organic Letters November 17, 2017 Volume 19(Issue 22) pp:6160-6160
Publication Date(Web):October 27, 2017
DOI:10.1021/acs.orglett.7b03050
Illisimonin A, an unprecedented sesquiterpenoid with a tricyclo[5.2.1.01,6]decane skeleton, was isolated from the fruits of Illicium simonsii. The structure and absolute configuration of 1 were determined using extensive spectroscopic evidence and electronic circular dichroism (ECD) calculations. It was determined that 1 possesses a caged 2-oxatricyclo[3,3,0,14,7]nonane ring system fused to a five-membered carbocyclic ring and a five-membered lactone ring. A plausible biogenetic pathway for 1 was proposed, and 1 showed neuroprotective effects against oxygen-glucose deprivation (OGD)-induced cell injury in SH-SY5Y cells with an EC50 value of 27.72 μM.
Co-reporter:Chang-Shan Niu, Yong Li, Yun-Bao Liu, Shuang-Gang Ma, Fei Liu, Li Li, Song Xu, Xiao-Jing Wang, Ru-Bing Wang, Jing Qu, and Shi-Shan Yu
Organic Letters 2017 Volume 19(Issue 4) pp:
Publication Date(Web):February 2, 2017
DOI:10.1021/acs.orglett.7b00048
Pierisketolide A (1) and pierisketones B and C (2 and 3), three diterpenes with an unusual A-homo-B-nor-ent-kaurane carbon skeleton, were isolated from the roots of Pieris formosa. Their structures were characterized by a series of spectroscopic methods, X-ray diffraction, and electronic circular dichroism (ECD). Pierisketolide A (1) exhibited an analgesic effect with a 45% writhe inhibition rate at a dose of 10.0 mg/kg. The plausible biosynthetic pathways of 1–3 are proposed.
Co-reporter:Chang-Shan Niu;Yong Li;Yun-Bao Liu;Shuang-Gang Ma;Fei Liu;Li Li;Song Xu;Xiao-Jing Wang;Sheng Liu;Ru-Bing Wang;Shi-Shan Yu
RSC Advances (2011-Present) 2017 vol. 7(Issue 69) pp:43921-43932
Publication Date(Web):2017/09/07
DOI:10.1039/C7RA08635K
Seventeen new 3,4-secograyanoids (1–17), together with seven known compounds (18–24), were isolated from the roots of Pieris formosa. Their structures with absolute configurations were characterized by a series of spectroscopic methods and X-ray diffraction. Compounds 1, 2, 4–8, 10–13, and 16–24 exhibited significant analgesic activity at 5.0 mg kg−1 (ip) compared to vehicle-injected mice (p < 0.05). In particular, compounds 16 and 17 showed highly potent activities with inhibition rates of 63.5% and 69.9%, respectively.
Co-reporter:Zhong-Hai Tang, Yun-Bao Liu, Shuang-Gang Ma, Li Li, Yong Li, Jian-Dong Jiang, Jing Qu, and Shi-Shan Yu
Organic Letters 2016 Volume 18(Issue 19) pp:5146-5149
Publication Date(Web):September 27, 2016
DOI:10.1021/acs.orglett.6b02572
Two pairs of oligomeric coumarin enantiomers, spirotriscoumarin A [(+)-1 and (−)-1] and spirotriscoumarin B [(+)-2 and (−)-2], with a spirodienone-sesquiterpene fused skeleton were isolated from Toddalia asiatica. Their structures were unambiguously established using spectroscopic data, X-ray diffraction analysis, and the electronic circular dichroism (ECD) method. The racemic mixtures (±)-1 and (±)-2 exhibit 3-to-6-fold stronger antiviral activity against influenza virus A (H3N2) (IC50: 3.13 and 2.87 μM, respectively) than their corresponding optically pure enantiomers.
Co-reporter:Chang-Shan Niu, Yong Li, Yun-Bao Liu, Shuang-Gang Ma, Li Li, Jing Qu, Shi-Shan Yu
Tetrahedron 2016 Volume 72(Issue 1) pp:44-49
Publication Date(Web):7 January 2016
DOI:10.1016/j.tet.2015.09.071
Eight new grayanane-type diterpenoids, pieristoxin L-S (1–8), and seven known diterpenoids, grayanoside D (9), rhodomolin I (10), pieristoxin H (11), grayanotoxin II (12), pierisformoside B (13), grayanoside C (14) and bis-deacetylkalmitoxin-VI (15), were isolated from the twigs of Pieris formosa. The structures of these compounds were elucidated using extensive spectroscopic analyses, including electronic circular dichroism (ECD). Pieristoxin L (1) is the first example of a 1,7-epoxy-grayanane-type diterpenoid. The analgesic activities of compounds 2–6, 8, and 10–15 were evaluated using an acetic acid-induced writhing test in mice. Compounds 3–6, 8, 10, 12, and 15 exhibited significant analgesic activity at 5 mg/kg (ip) compared to vehicle-injected mice (P<0.01). The writhe inhibition rates of compounds 3, 5, and 6 at 0.08 mg/kg (ip) were 37.6%, 56.8% and 49.8%, respectively. The control drug morphine achieved comparable writhe inhibition at a 10-fold dose.
Co-reporter:Hong-Shun Gu, Shuang-Gang Ma, Yu-Huan Li, Ya-Dan Wang, Yun-Bao Liu, Li Li, Yong Li, Jing Qu, Hai-Ning Lv, Xiao-Guang Chen, Jian-Dong Jiang, Shi-Shan Yu
Tetrahedron 2014 70(41) pp: 7476-7483
Publication Date(Web):
DOI:10.1016/j.tet.2014.08.021
(-)-(1R,3R)-palmarumycin BG3
Ymf 1029 D
2-Cyclohexen-1-one, 6-hydroxy-3-(3-hydroxybutyl)-2,4,4-trimethyl-
bipendensin
2-Cyclohexen-1-one, 4-hydroxy-4-[(1E,3S)-3-hydroxy-1-butenyl]-3,5,5-trimethyl-, (4S)-
preussomerin C
(3S,4E)-5-[(1S,4S,5S,8R)-4,8-dimethyl-2,3-dioxabicyclo[3.3.1]non-4-yl]-2-methylpent-4-ene-2,3-diol
1H-2-Benzoxacyclododecin-1-one,3,4,5,6,7,8,9,10-octahydro-12-hydroxy-14-methoxy-3-methyl-, (3S)-
2-Cyclohexen-1-one,4-hydroxy-4-[(1E,3R)-3-hydroxy-1-buten-1-yl]-3,5,5-trimethyl-, (4S)-
5-oxopseudostrychnine